CHAPEL HILL, N.C.--(BUSINESS WIRE)--April 14, 2005--POZEN Inc.
(NASDAQ:POZN), announced today that it will release first quarter
results on April 28, 2005, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m.
Eastern Time of a discussion by POZEN management of the financial and
business results. The webcast can be accessed on POZEN's website at
www.pozen.com and will be archived and available for replay. The first
quarter financial release can be accessed in the News section of
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of migraine. POZEN is
also exploring the development of product candidates in other
pain-related therapeutic areas. POZEN has development and commercial
alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN". For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN Inc.
Bill Hodges, 919-913-1030
Fran Barsky, 919-913-1044
SOURCE: POZEN Inc.